文献速递儿科与产科急症重症综合管理与镇静镇痛

脑组织氧饱和度指导早产儿出生后即刻过渡期氧输送(COSGOD III):多中心随机3期临床试验

Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial.
PubMed 文献 · BMJ · 2023-01-24
一句话结论对胎龄<32周早产儿,出生后即刻过渡与复苏时在常规监测基础上加用近红外光谱监测脑组织氧饱和度并按专门治疗指南干预,未显著提高无脑损伤生存率(RR 1.06,95%CI 0.98-1.14)。

COSGOD III为多中心、跨国、随机对照3期试验,在欧洲6国及加拿大的11个三级新生儿重症监护病房进行,产前筛查1121名<32周孕妇,655名早产儿随机,主要结局分析607例(近红外光谱组304例、对照组303例)。干预为常规护理加近红外光谱监测脑组织氧饱和度并按专门治疗指南处理,时段为出生后最初15分钟的即刻过渡与复苏。主要复合结局为无脑损伤生存(脑损伤定义为相当于足月龄或出院前任何脑室内出血或囊性脑室周围白质软化,或两者兼有):近红外光谱组252/304(82.9%)vs 对照组238/303(78.5%),RR 1.06(95%CI 0.98-1.14);死亡12/304(4.0%)vs 16/303(5.3%),RR 0.75(95%CI 0.33-1.70)。结论为与单纯标准护理相比,该策略未使无脑损伤生存率显著提高,绝对值增加4.3%但无统计学意义。

要点

  • 胎龄<32周早产儿出生后最初15分钟即刻过渡与复苏时,近红外光谱组与对照组脑组织氧饱和度相似。
  • 主要复合结局无脑损伤生存:近红外光谱组252/304(82.9%)vs 对照组238/303(78.5%),RR 1.06(95%CI 0.98-1.14),未达统计学显著。
  • 死亡:近红外光谱组12/304(4.0%)vs 对照组16/303(5.3%),RR 0.75(95%CI 0.33-1.70)。
  • 无脑损伤生存率绝对值增加4.3%,但无统计学意义。
  • 脑损伤定义为相当于足月龄或出院前任何脑室内出血或囊性脑室周围白质软化,或两者兼有。

适用人群与场景

  • 产前筛查1121名胎龄<32周的孕妇;随机655名早产儿,主要结局分析607例(近红外光谱组304例、对照组303例)。
  • 近红外光谱组中位胎龄28.9周(四分位距26.9-30.6周),对照组28.6周(26.6-30.6周)。
  • 场景为出生后即刻过渡与复苏的最初15分钟,在11个三级新生儿重症监护病房进行。

诊断标准与关键阈值

  • 脑损伤定义:相当于足月龄或出院前任何脑室内出血或囊性脑室周围白质软化,或两者兼有。
  • 主要复合结局:无脑损伤生存,采用全因死亡与系列颅脑超声评估。

处置流程与药物剂量

  • 近红外光谱组:常规护理加近红外光谱监测脑组织氧饱和度,并依据专门治疗指南进行干预,时段为出生后最初15分钟的即刻过渡与复苏。
  • 对照组:仅标准护理。

研究设计与关键结果

  • 多中心、跨国、随机对照3期试验,11个三级新生儿重症监护病房,位于欧洲6国及加拿大;655名早产儿随机,607例纳入主要结局分析。
  • 主要结局无脑损伤生存:近红外光谱组252/304(82.9%)vs 对照组238/303(78.5%),RR 1.06(95%CI 0.98-1.14)。
  • 死亡:近红外光谱组12/304(4.0%)vs 对照组16/303(5.3%),RR 0.75(95%CI 0.33-1.70)。
  • 两组脑组织氧饱和度相似。
  • 无脑损伤生存率绝对值增加4.3%,但无统计学意义。

证据类型、等级与局限

  • 证据类型:多中心、跨国、随机对照3期临床试验。
  • 试验注册:ClinicalTrials.gov NCT03166722。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:对胎龄<32周早产儿,出生后即刻过渡与复苏时在常规监测基础上加用近红外光谱监测脑组织氧饱和度并按专门治疗指南干预,与单纯标准护理相比未使无脑损伤生存率显著提高。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate whether monitoring of cerebral tissue oxygen saturation using near infrared spectroscopy in addition to routine monitoring combined with defined treatment guidelines during immediate transition and resuscitation increases survival without cerebral injury of premature infants compared with standard care alone.

DESIGN: Multicentre, multinational, randomised controlled phase 3 trial.

SETTING: 11 tertiary neonatal intensive care units in six countries in Europe and in Canada.

PARTICIPANTS: 1121 pregnant women (<32 weeks' gestation) were screened prenatally. The primary outcome was analysed in 607 of 655 randomised preterm neonates: 304 neonates in the near infrared spectroscopy group and 303 in the control group.

INTERVENTION: Preterm neonates were randomly assigned to either standard care (control group) or standard care plus monitoring of cerebral oxygen saturation with a dedicated treatment guideline (near infrared spectroscopy group) during immediate transition (first 15 minutes after birth) and resuscitation.

MAIN OUTCOME MEASURE: The primary outcome, assessed using all cause mortality and serial cerebral ultrasonography, was a composite of survival without cerebral injury. Cerebral injury was defined as any intraventricular haemorrhage or cystic periventricular leukomalacia, or both, at term equivalent age or before discharge.

RESULTS: Cerebral tissue oxygen saturation was similar in both groups. 252 (82.9%) out of 304 neonates (median gestational age 28.9 (interquartile range 26.9-30.6) weeks) in the near infrared spectroscopy group survived without cerebral injury compared with 238 (78.5%) out of 303 neonates (28.6 (26.6-30.6) weeks) in the control group (relative risk 1.06, 95% confidence interval 0.98 to 1.14). 28 neonates died (near infrared spectroscopy group 12 (4.0%) v control group 16 (5.3%): relative risk 0.75 (0.33 to 1.70).

CONCLUSION: Monitoring of cerebral tissue oxygen saturation in combination with dedicated interventions in preterm neonates (<32 weeks' gestation) during immediate transition and resuscitation after birth did not result in substantially higher survival without cerebral injury compared with standard care alone. Survival without cerebral injury increased by 4.3% but was not statistically significant.

TRIAL REGISTRATION: ClinicalTrials.gov NCT03166722.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Pichler G, Goeral K, Hammerl M, et al. Cerebral regional tissue Oxygen Saturation to Guide Oxygen Delivery in preterm neonates during immediate transition after birth (COSGOD III): multicentre randomised phase 3 clinical trial. BMJ. 2023. PMID: 36693654. doi:10.1136/bmj-2022-072313

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。